Qingdao NovelBeam Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical endoscopic instruments and optical prod...
NovelBeam Technology: As of the end of October, a total of 50.0134 million yuan worth of shares have been repurchased
NovelBeam Technology: Net profit in the first three quarters increased by 40.03% year-on-year
NovelBeam Technology: The controlling shareholder plans to reduce its holdings by no more than 2.7345% of the company's shares
The concerted actor of the actual controller of NovelBeam Technology, Ma Min, intends to reduce holdings by no more than 252,000 shares
NovelBeam Technology: Shareholder's reduction plan deadline has passed without any reduction
NovelBeam Technology released its first-quarter performance, with a net profit attributable to the parent company of 46.69 million yuan, a year-on-year increase of 21.45%